About this Journal Submit a Manuscript Table of Contents
PPAR Research
Volume 2012 (2012), Article ID 304760, 23 pages
http://dx.doi.org/10.1155/2012/304760
Review Article

PPARs: Interference with Warburg’ Effect and Clinical Anticancer Trials

1Inserm, HMNO, CBP, CHRU Lille, 59037 Lille, France
2Biochemistry and Molecular Biology, HMNO, CBP, CHRU Lille, 59037 Lille, France
3Department of Human Biology and Toxicology, Faculty of Medicine and Pharmacy, UMons, 7000 Mons, Belgium
4Organic Chemistry Laboratory, Faculty of Sciences, UMons, 7000 Mons, Belgium
5Inserm U1065, IFR 50, Mediterranean Center of Molecular Medicine, 06204 Nice, France

Received 14 December 2011; Revised 15 February 2012; Accepted 19 February 2012

Academic Editor: Dipak Panigrahy

Copyright © 2012 Joseph Vamecq et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Joseph Vamecq, Jean-Marie Colet, Jean Jacques Vanden Eynde, Gilbert Briand, Nicole Porchet, and Stéphane Rocchi, “PPARs: Interference with Warburg’ Effect and Clinical Anticancer Trials,” PPAR Research, vol. 2012, Article ID 304760, 23 pages, 2012. doi:10.1155/2012/304760